Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Single Tissue Sample Reveals Breast Cancer Spread

By HospiMedica staff writers
Posted on 14 Feb 2007
A single tissue sample revealed if breast cancer has spread. More...
That means the most aggressive cancer types can be detected at an early stage.

A new method makes it possible to detect the most aggressive types of breast cancer far earlier than previously. At the same time, women with a 'mild' type could be notified quickly that they are out of danger and not have to carry their fears for months without reason.

Ingrid Gribbestad and colleagues at the MR Centre at The Norwegian University of Science and Technology (NTNU, Trondheim, Norway) have developed a new method which involves looking at the biopsies (breast tissue samples) at the molecular level. Today, we have to study the cancerous tumors in microscopes and observe the dangerous changes with our bare eyes. We operate on the lower level when it comes to size, Dr.Gribbestad said.

The method involves taking a 'fingerprint' of the molecules in the tissue sample. This is the first time that the method has been used for breast cancer. There is no doubt that we are at the top internationally in this area, said Dr. Gribbestad.

Dr. Gribbestad can report something about the behavior of a particular cancerous tumor if she knows the history and the molecules of the tumor in question. That makes it possible, for instance, to establish whether the cancer in this tissue has spread to lymph nodes elsewhere in the body. Another positive aspect is that this 'fingerprint' also indicates whether the patient will respond to the medical treatment we initiate, Dr. Gribbestad explained.

That makes it possible to find the patients who should be given chemotherapy even before the operation. In addition, cases where it is safe to remove only the affected tissue instead of the entire breast will be easier to find, meaning that more breasts will be spared.

With this we leave the group treatment for the benefit of individual treatment adapted to each patient's disease profile, concluded Ingrid Gribbestad.



Related Links:
The Norwegian University of Science and Technology

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Multi-Chamber Washer-Disinfector
WD 390
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.